SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001610618-24-000030
Filing Date
2024-04-01
Accepted
2024-04-01 08:00:11
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-01

Document Format Files

Seq Description Document Type Size
1 NOTIFICATION OF LATE FILING cdtxnt10-k2024x04x01.htm NT 10-K 41352
  Complete submission text file 0001610618-24-000030.txt   42582
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 001-36912 | Film No.: 24805611
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)